Results
12
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
12 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
540737 | ₹670.35 | -5.7% | 10.0% | ₹9.0b | n/a | PE30.9x | n/a | 0% | ||
AJANTPHARM | ₹2,945.50 | 3.0% | 50.1% | ₹366.4b | ₹2,992.82 | PE42x | E16.4% | 1.9% | ||
NATCOPHARM | ₹1,374.75 | -0.1% | 74.2% | ₹244.4b | ₹1,343.09 | PE12.7x | E-20.4% | 0.2% | ||
500420 | ₹3,104.55 | 0.07% | 47.4% | ₹1.0t | ₹3,596.55 | PE58.3x | E22.7% | 0.9% | ||
500488 | ₹27,145.25 | -0.7% | 13.6% | ₹577.8b | ₹28,117.14 | PE44.9x | E11.0% | 1.5% | ||
524632 | ₹58.28 | -11.7% | 168.3% | ₹2.6b | n/a | PE17.7x | n/a | 1.7% | ||
JSLL | ₹1,931.55 | 6.7% | 186.7% | ₹47.7b | n/a | PE57x | n/a | 0.2% | ||
INDSWFTLAB | ₹102.71 | -3.1% | 10.0% | ₹6.1b | n/a | PE1.6x | n/a | n/a | ||
524212 | ₹211.00 | -8.3% | 116.3% | ₹7.3b | n/a | PE13.1x | n/a | n/a | ||
539561 | ₹6.07 | -5.6% | -76.0% | ₹2.5b | n/a | PE10.2x | n/a | n/a | ||
531569 | ₹284.20 | -5.8% | 98.6% | ₹3.4b | n/a | PE48x | n/a | n/a | ||
BETA | ₹1,983.00 | -3.1% | 76.9% | ₹19.4b | n/a | PE46.5x | n/a | n/a |